Developing a Comprehensive Treatment and Funding Strategy to Improve Drug X Adherence
The client’s primary objective was to enhance treatment persistence for Drug X, designed for Alzheimer’s Disease (AD) patients. They aimed to identify patient access initiatives that could improve long-term adherence to the treatment, ultimately increasing the drug’s effectiveness and patient outcomes. The client was facing significant challenges related to the persistence of AD patients in continuing treatment with Drug X. They observed that many patients were discontinuing the therapy prematurely, which affected the drug’s overall success. To address this, a comprehensive assessment was needed to explore factors hindering patient adherence and to identify actionable strategies for improving access to support mechanisms. Are you curious about how we helped a client improve treatment persistence for Alzheimer’s Disease patients by identifying targeted patient access initiatives? Discover how we addressed the challenge of premature therapy discontinuation, enhanced long-term adherence, and ultimately increased the effectiveness and success of their innovative drug. Fill out the form to access the full case study.Objective
Challenges faced by the client